M H O'Dea
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by M H O'Dea.
Cell Biochemistry and Biophysics | 1988
Hans V. Westerhoff; M H O'Dea; Anthony Maxwell; Martin Gellert
Using purified DNA gyrase to supercoil circular plasmid pBR322 DNA, we examined how the linking number attained at the steady state (‘static head’) varies with the concentrations of ATP and ADP, both in the absence and presence of spermidine. In the absence of spermidine at total adenine nucleotide concentrations between 0.35 and 1.4 mM, the static-head linking number was independent of the sum concentration of ATP and ADP, but depended strongly on the ratio of their concentrations. We established that the same linking number was attained independent of the direction from which the steady state was approached. The decrease in linking number at static head is more extensive when spermidine is present in the incubation, but remains a function of the [ATP]-to-[ADP] ratio.These results are discussed in terms of various kinetic schemes for DNA gyrase. We present one kinetic scheme that accounts for the experimental observations. According to this scheme our experimental results imply that there is significant slip in DNA gyrase when spermidine is absent. It is possible that spermidine acts through adjustment of the degree of coupling of DNA gyrase.
Proceedings of the National Academy of Sciences of the United States of America | 2002
Meni Melek; Jessica M. Jones; M H O'Dea; Godwin Pais; Terrence R. Burke; Yves Pommier; Nouri Neamati; Martin Gellert
Assembly of functional Ig and T cell receptor genes by V(D)J recombination depends on site-specific cleavage of chromosomal DNA by the RAG1/2 recombinase. As RAG1/2 action has mechanistic similarities to DNA transposases and integrases such as HIV-1 integrase, we sought to determine how integrase inhibitors of the diketo acid type would affect the various activities of RAG1/2. Both of the inhibitors we tested interfered with DNA cleavage and disintegration activities of RAG1/2, apparently by disrupting interaction with the DNA motifs bound specifically by the recombinase. The inhibitors did not ablate RAG1/2s transposition activity or capture of nonspecific transpositional target DNA, suggesting this DNA occupies a site on the recombinase different from that used for specific binding. These results further underscore the similarities between RAG1/2 and integrase and suggest that certain integrase inhibitors may have the potential to interfere with aspects of B and T cell development.
Proceedings of the National Academy of Sciences of the United States of America | 1976
Martin Gellert; Kiyoshi Mizuuchi; M H O'Dea; Howard A. Nash
Proceedings of the National Academy of Sciences of the United States of America | 1977
Martin Gellert; Kiyoshi Mizuuchi; M H O'Dea; Tateo Itoh; Jun-ichi Tomizawa
Proceedings of the National Academy of Sciences of the United States of America | 1976
Martin Gellert; M H O'Dea; Tateo Itoh; Jun-ichi Tomizawa
Proceedings of the National Academy of Sciences of the United States of America | 1978
Kiyoshi Mizuuchi; M H O'Dea; Martin Gellert
Proceedings of the National Academy of Sciences of the United States of America | 1980
Kiyoshi Mizuuchi; L M Fisher; M H O'Dea; Martin Gellert
Nucleic Acids Research | 1987
Toshiro Adachi; Michiyo Mizuuchi; Elizabeth A. Robinson; Ettore Appella; M H O'Dea; Martin Gellert; Kyoshi Mizuuchi
Proceedings of the National Academy of Sciences of the United States of America | 1981
L M Fisher; Kiyoshi Mizuuchi; M H O'Dea; H Ohmori; Martin Gellert
Proceedings of the National Academy of Sciences of the United States of America | 1983
Martin Gellert; M H O'Dea; Kiyoshi Mizuuchi